Login / Signup

Impact of low molecular weight heparin administration on the clinical course of the COVID-19 disease

Burcu YormazDilek ErgunBaykal TülekRecai ErgünUğur ArslanFikret Kanat
Published in: Turkish journal of medical sciences (2021)
The LMWH treatment group demonstrated better laboratory findings, including recovery in the lymphocyte count, CRP, and D-dimer results.
Keyphrases
  • coronavirus disease
  • sars cov
  • peripheral blood
  • venous thromboembolism
  • growth factor
  • respiratory syndrome coronavirus